Goldman Sachs Group Inc Axsome Therapeutics, Inc. Put Options Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$69.25 - $82.21 $2.45 Million - $2.91 Million
35,400 New
35,400 $2.47 Million
Q4 2022

May 14, 2024
SELL
$39.94 - $79.72 $607,088 - $1.21 Million
-15,200 Reduced 42.94%
20,200 $1.56 Million
Q4 2022

Feb 13, 2023
BUY
$39.94 - $79.72 $806,788 - $1.61 Million
20,200 New
20,200 $1.56 Million

Others Institutions Holding AXSM

# of Institutions
325
Shares Held
37.7M
Call Options Held
912K
Put Options Held
855K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.77B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email